1.201 - 1.225 of 32.999
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Amazon.com Call 214,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,00x
- Analysis
- Teva Pharmaceutical Industries Call 17,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,18x
- Analysis
- Fresenius Medical Care Call 50,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 3,80x
- Analysis
- Fresenius Medical Care Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,75x
- Analysis
- Amazon.com Call 228,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,42x
- Analysis
- Novo Nordisk Call 265,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,70x
- Analysis
- Novo Nordisk Call 335,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,07x
- Analysis
- Amazon.com Call 232,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 16,13x
- Analysis
- Sempra Energy Call 100,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 15,25x
- Analysis
- Continental Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 9,50x
- Analysis
- Amazon.com Call 226,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 13,75x
- Analysis
- Novo Nordisk Call 305,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,79x
- Analysis
- Prosus NV Call 54,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 11,40x
- Analysis
- Novo Nordisk Call 285,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,28x
- Analysis
- Cummins Inc Call 360,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,26x
- Analysis
- Amazon.com Call 234,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 17,28x
- Analysis
- Novo Nordisk Call 315,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 5,09x
- Analysis
- Beyond Meat USD Call 2,50 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 2,20x
- Analysis
- Amazon.com Call 224,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 12,97x
- Analysis
- Swiss Life Holding Call 860,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,95x
- Analysis
- Novo Nordisk Call 295,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,51x
- Analysis
- Novo Nordisk Call 345,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,49x
- Analysis
- Novo Nordisk Call 325,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 6,63x
- Analysis
- Novo Nordisk Call 315,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 6,60x
- Analysis
- Novo Nordisk Call 510,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,08x
- Analysis